| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |